Refanezumab
Refanezumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients).
| Trade Name | Refanezumab |
| Generic | Refanezumab |
| Refanezumab Other Names | Refanezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Refanezumab
